LOESTRIN 24 FE (nda021871)- (0.02MG;1MG)

Generic Name	ETHINYL ESTRADIOL; NORETHINDRONE ACETATE	Innovator	TEVA BRANDED PHARM
Dosage	0.02MG;1MG
ParaIV Filing	Yes	505(b)2 Filing	No
Last Patent Expiry	2014-Jul-22	NCE Excl Expiry	Expired
ODE Expiry	None	NP Expiry	None
GAIN Expiry	None	Drug Complexity	No
Indication	LOESTRIN are indicated for the prevention of pregnancy in women who elect to use oral contraceptives as a method of contraception.

Approvals and Launches

Final Approvals	Tentative Approvals	Generic Launches
8	0	7

Other Developers

Total Other Developers	None

Drugs with Suitability

Drugs with Suitability	No

Drug Pricing

	NDA			ANDA
Dosage	Weekly	Monthly	Yearly	Yearly Up	Yearly Down
0.02MG;1MG	**	**	-	-	5

Drug Sales

NDA Sales Available	Total Generic Sales Available
No	5

Manufacturing Details of LOESTRIN 24 FE